Search for: "IPR Pharmaceuticals, Inc."
Results 101 - 120
of 182
Sorted by Relevance
|
Sort by Date
18 May 2016, 8:19 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 Apr 2016, 9:58 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]
15 Apr 2021, 10:51 am
Retroactive Application of IPRs: Security People, Inc. v. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
28 Jun 2016, 6:41 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Exhaustion: Impression Products, Inc. v. [read post]
26 Oct 2007, 1:00 am
(IP Law360),LG Electronics Inc. has settled a lawsuit it brought against China's number-one television maker over digital television patents (IP Law 360), SanDisk Corp. has filed patent actions against 25 flash memory companies to stop the manufacture, sale or import of their allegedly infringing products: (IP Law 360). [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
17 Feb 2016, 9:20 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
3 Feb 2016, 8:57 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
23 Nov 2007, 9:00 am
Astra's Data Exclusivity prevents a European generic launch, until at least 2010.: (Generic Pharmaceuticals & IP), Iressa (gefitinib) - Astrazeneca's Indian patent application rejected: (Generic Pharmaceuticals & IP), Ziagen (Abacavir Hemisulfate Salt) -GSK's application [872/CAL/98; corresponding to Orange Book listed US6294540] opposed by Indian Network for People living with HIV/ AIDS and then withdrawn by GSK: (Generic Pharmaceuticals… [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
29 May 2024, 11:27 am
Regeneron Pharmaceuticals, Inc. v. [read post]
12 Jan 2016, 11:39 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v… [read post]
26 Sep 2022, 4:49 am
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
17 Mar 2016, 2:45 am
Lee, No. 15-446 (BRI construction in IPRs; institution decisions unreviewable) 2. [read post]
28 Apr 2013, 10:39 pm
Anubha followed this up with an update on the Indo-EU FTA negotiations, including India’s positive stance that it cannot go beyond the parameters of the TRIPS and its domestic IPR laws and its demand of being declared a data-secure country. [read post]
